Biofrontera Statistics

Share Statistics

Biofrontera has 0 shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Institutions (%)	n/a
Shares Floating	n/a
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 9.96K, so 0% of the outstanding shares have been sold short.

Short Interest	9.96K
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1

Valuation Ratios

The PE ratio is -12.75 and the forward PE ratio is null. Biofrontera's PEG ratio is -0.3.

PE Ratio	-12.75
Forward PE	n/a
PS Ratio	5.47
Forward PS	n/a
PB Ratio	22.51
P/FCF Ratio	-45.81
PEG Ratio	-0.3

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Biofrontera.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.15, with a Debt / Equity ratio of 3.24.

Current Ratio	3.15
Quick Ratio	2.59
Debt / Equity	3.24
Debt / EBITDA	-5.57
Debt / FCF	-6.59
Interest Coverage	-2.47

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$203.66K
Profits Per Employee	$-87.4K
Employee Count	149
Asset Turnover	0.54
Inventory Turnover	0.76

Taxes

Income Tax	326K
Effective Tax Rate	-2.57%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 1.55, so Biofrontera's price volatility has been higher than the market average.

Beta	1.55
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	42.81
Average Volume (20 Days)	30,523

Income Statement

In the last 12 months, Biofrontera had revenue of 30.35M and earned -13.02M in profits. Earnings per share was -0.47.

Revenue	30.35M
Gross Profit	26.81M
Operating Income	-7.61M
Net Income	-13.02M
EBITDA	-4.28M
EBIT	-9.62M
Earnings Per Share (EPS)	-0.47

Full Income Statement

Balance Sheet

The company has 16.55M in cash and 23.88M in debt, giving a net cash position of -7.33M.

Cash & Cash Equivalents	16.55M
Total Debt	23.88M
Net Cash	-7.33M
Retained Earnings	-165.73M
Total Assets	n/a
Working Capital	n/a

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.85M and capital expenditures -774K, giving a free cash flow of -3.62M.

Operating Cash Flow	-2.85M
Capital Expenditures	-774K
Free Cash Flow	-3.62M
FCF Per Share	-0.13

Full Cash Flow Statement

Margins

Gross margin is 88.35%, with operating and profit margins of -25.08% and -42.92%.

Gross Margin	88.35%
Operating Margin	-25.08%
Pretax Margin	-41.84%
Profit Margin	-42.92%
EBITDA Margin	-14.12%
EBIT Margin	-25.08%
FCF Margin	-11.94%

Dividends & Yields

BFRA pays an annual dividend of $0.13, which amounts to a dividend yield of 1.62%.

Dividend Per Share	$0.13
Dividend Yield	1.62%
Dividend Growth (YoY)	370.14%
Payout Ratio	-20.52%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for BFRA.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a

Biofrontera AG (BFRA)